Switching Between Intravenous and Oral P2Y12 Inhibition: Easier Said Than Done
Adequate suppression of platelet reactivity is necessary to mitigate early thrombotic events, including stent thrombosis, among patient undergoing percutaneous coronary intervention (PCI). Clinical trials conducted…